Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Open this folder and view contentsIII. Second workshop
Close this folderIV. Preliminary findings
Open this folder and view contents1. The methods: What has been learnt?
Close this folder2. National drug policies: what has been learnt?
View the document2.1 Preliminary findings based on NDP indicators
View the document2.2 Preliminary interpretations based on NDP indicators
View the document2.3 Preliminary findings based on the political mapping
Open this folder and view contents3. Cross national analysis: What can be learnt at this stage?
View the document4. Broader capacity building
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series

2. National drug policies: what has been learnt?

The main aim of the research was to assess if national drug policies (whether explicit or implicit) have been successful in achieving availability and accessibility to essential drugs, quality and rational use of drugs and to understand why and why not. The participants therefore reviewed the data obtained from the indicators and the information provided with the political mapping. As the data were not completed for all the countries and were not available to the coordinators before the workshop, it was not possible to go into detail in all these aspects; however, some preliminary analysis and interpretation of results could be made which opened exciting avenues for the next steps of the research. These preliminary results are presented separately for the indicators and for the political mapping as they were discussed separately during the workshop.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017